Skip to Content
Merck
CN

13635

1-Z-4-Piperidone

purum, ≥95.0% (HPLC)

Synonym(s):

1-(Benzyloxycarbonyl)-4-piperidinone, 1-Cbz-4-Piperidone, Benzyl 4-oxo-1-piperidinecarboxylate

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C13H15NO3
CAS Number:
Molecular Weight:
233.26
Beilstein/REAXYS Number:
1533716
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
≥95.0% (HPLC)
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

SMILES string

O=C1CCN(CC1)C(=O)OCc2ccccc2

InChI

1S/C13H15NO3/c15-12-6-8-14(9-7-12)13(16)17-10-11-4-2-1-3-5-11/h1-5H,6-10H2

InChI key

VZOVOHRDLOYBJX-UHFFFAOYSA-N

grade

purum

assay

≥95.0% (HPLC)

form

solid

Quality Level

bp

114-140 °C/0.25 mmHg (lit.)

density

1.172 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

General description

1-Z-4-Piperidone is the starting material in biheteroaromatic diphosphine oxides-catalyzed stereoselective direct aldol condensation reactions.

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Eyeshields, Gloves

Regulatory Information

危险化学品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Biheteroaromatic diphosphine oxides-catalyzed stereoselective direct aldol reactions.
Rossi S, et al.
Tetrahedron, 67(1), 158-166 (2011)
Svetlana Paskaš et al.
Molecular carcinogenesis, 58(8), 1362-1375 (2019-04-19)
The main focus of this study is exploring the effect and mechanism of two HIV-protease inhibitors: Ritonavir and Ritonavir-nitric oxide (Ritonavir-NO) on in vitro growth of melanoma cell lines. NO modification significantly improved the antitumor potential of Ritonavir, as the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service